AZD2014,AZD4547,AZD5363,AZD8931,Selumetinib,Vandetanib,Pemetrexed,Durvalumab,savolitinib,Olaparib,pembrolizumab
oncosec medical,merck,astrazeneca,hutchmed
['tavo', 'sclc', 'nsclc', 'pembro', 'lung']
great presentation from filippo gustavo dall'olio on the unicancer safir02-lung/ifct1301 trial at #asco23. read about early plasma ctdna changes that predict response to first-line pembrolizumab-based therapy in nsclc from et al in #jitc. 
The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Interim Editor-in-Chief: James L. Gulley (@gulley1)